Diet in subjects with irritable bowel syndrome: A cross-sectional study in the general population by Solveig C Ligaarden et al.
Ligaarden et al. BMC Gastroenterology 2012, 12:61
http://www.biomedcentral.com/1471-230X/12/61RESEARCH ARTICLE Open AccessDiet in subjects with irritable bowel syndrome: A
cross-sectional study in the general population
Solveig C Ligaarden1,2*, Stian Lydersen3 and Per G Farup2,4Abstract
Background: Patients with irritable bowel syndrome (IBS) often relate symptoms to the intake of certain foods. This
study assesses differences in diet in subjects with and without IBS.
Methods: The cross-sectional, population-based study was conducted in Norway in 2001. Out of 11078 invited
subjects, 4621 completed a survey about abdominal complaints and intake of common food items. IBS and IBS
subgroups were classified according to Rome II criteria.
Results: IBS was diagnosed in 388 subjects (8.4%) and, of these, 26.5% had constipation-predominant IBS (C-IBS),
44.8% alternating IBS (A-IBS), and 28.6% diarrhoea-predominant IBS (D-IBS). Low intake of dairy products (portions/
day) (Odds Ratio 0.85 [CI 0.78 to 0.93], p= 0.001) and high intake of water (100 ml/day) (1.08 [1.02 to 1.15],
p= 0.002), tea (1.05 [1.01 to 1.10], p= 0.019) and carbonated beverages (1.07 [1.01 to 1.14], p= 0.023) were
associated with IBS. A lower intake of dairy products and a higher intake of alcohol and carbonated beverages were
associated with D-IBS and a higher intake of water and tea was associated with A-IBS. In subjects with IBS the
severity of symptoms was associated with a higher intake of vegetables and potatoes in subjects with C-IBS, with a
higher intake of vegetables in subjects with A-IBS, and with a higher intake of fruits and berries, carbonated
beverages and alcohol in subjects with D-IBS.
Conclusions: In this study, the diet differed in subjects with and without IBS and between IBS subgroups and was
associated with the severity of symptoms.
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Functional gastrointestinal disorders are common in
developed countries, and irritable bowel syndrome (IBS)
is the most frequent disorder with a prevalence of 5–
10% [1]. IBS generates a considerable workload and con-
stitutes 36% of all visits to gastroenterologists [2]. The
treatment is not adequate.
Approximately two-thirds of subjects with IBS relate their
symptoms to their intake of food [3,4]. Most of these sub-
jects modify their diet, and these modifications sometimes
result in an inadequate diet [3]. On the other hand, some
subjects with IBS may not be aware of all the offending* Correspondence: solveig.ligaarden@ntnu.no
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reproduction in any medium, provided the oritems. Despite reports of symptoms related to food intake,
investigations of food intake in IBS have been sparse. One
study conducted in the general population reported no
differences in the consumption of specific food items
between subjects with functional gastrointestinal disorders
and controls [5], while another study, conducted in
secondary care, reported the consumption of a poorer
quality diet by subjects with IBS [6]. Except for the previ-
ously mentioned population-based study, the diet of sub-
jects with IBS in the general population has to our
knowledge not been investigated. We hypothesised that diet
was associated with IBS, IBS subgroups and severity of
symptoms in a general population-based sample. Therefore,
the primary aim of the present study was to assess differ-
ences in the diets of subjects with and without IBS. The
secondary aims were to assess differences between IBS sub-
groups and between IBS subgroups and the populationral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of symptoms and diet within the IBS-population.Methods
The OPPHED (Oppland and Hedmark counties) Health
Study was conducted in 2000 - 2001 as a cross-sectional
study by the National Health Screening Service (now the
Norwegian Institute of Public Health). In this part of the
study, all men and women living in Oppland County
who were born in 1925, 1940, 1955, 1960 and 1970 were
invited to participate.Invited to health screening in Oppland county = 11078 
Did not attend screening = 4880 
Attended the screening = 6198 
Did not answer = 1577 
Filled in questionnaires about abdominal complaints and diet = 4621 
With IBS = 388 (8.4%) Without IBS = 4233 
Adequate information about 
severity of symptoms = 377 
Inadequate information about 
severity of symptoms =10 
Figure 1 Flow chart.Assessments
Subjects were asked to complete questionnaires in paper
form on their own. The food and drink questions in our
study were equal to the food and drink questions in The
Oslo Health Study (an English translation is available
[7]). The following information was derived from the
answers to the questions: demographics, common dis-
eases (asthma, bronchitis, diabetes, osteoporosis, fibro-
myalgia, mood disorders, heart attack, angina, cerebral
stroke) (number of diseases, score 0-9), mood disorders
measured by Hopkins Symptom Checklist (HSCL10)
(score 1.0-4.0, mental distress ≥ 1.85), musculoskeletal
complaints (score 0-12), smoking habits, activity habits,
diet, and gastrointestinal symptoms. IBS was defined
according to the Rome II criteria [8] and IBS subgroups
were classified as constipation-predominant IBS (C-IBS),
alternating IBS (A-IBS), or diarrhoea-predominant IBS
(D-IBS). The severity of symptoms (score 1-12) was cal-
culated as the product of severity (mild, moderate, severe
(score 1-3)) and frequency (one day or less per week,
two to three days per week, four to five days per week,
more than five days per week (score 1-4)) The diet was
assessed using a limited food frequency questionnaire
(FFQ), and questions included the frequency and quan-
tity of the intake of beverages (milk, water, carbonated
beverages, and alcoholic beverages), fruits, vegetables,
fatty fish, cheese, and omega-3 fatty acid supplements,
but did not include the food groups cereals and meat.
For the analyses, dairy product portions were classified
as either 150 ml milk/yoghurt or 20 g (one slice) of
cheese. Body mass index (BMI) was calculated by means
of measured weight and height. Diastolic and systolic
blood pressure and pulse were measured. Blood samples
were taken and standard blood tests were performed
(cholesterol, high-density lipoprotein (HDL), triglycer-
ides, glucose, creatinine clearance). Blood levels of
omega 3 fatty acids (22:6(n-3) + 22:5(n-3) + 20:5(n-3))
from fatty fish and fish oil supplements were measured
in 60 subjects with IBS and in 60 controls. The method
used was described for the first time by Bonaa et al. [9].Statistical methods
Data were analysed with PASW Statistics 18.0 (SPSS,
Chicago, Illinois, USA).
Differences between subjects with and without IBS
were assessed with Mann-Whitney U test, Chi-square
test, and logistic regression analyses. Differences between
the three subgroups of IBS were assessed with the Krus-
kal-Wallis Test and Chi-square test, followed by pairwise
comparisons when the overall test was significant. Logis-
tic regression analyses were used to assess differences be-
tween each of the three IBS subgroups (C-IBS, A-IBS,
and D-IBS) versus subjects without IBS. Associations be-
tween the severity of symptoms and IBS subgroups were
assessed with ordinal logistic regression analyses. In
situations with fewer than 10 observations per covariate,
we used backward stepwise elimination terminating in
models that included age, gender, HSCL10, and musculo-
skeletal complaints, and as many other covariates as pos-
sible with at least 10 cases per covariate.
For the regression analyses, missing values were
handled by multiple imputations. All variables to be
included in the regression analyses were included in the
imputation model. Right-skewed variables were log-
transformed before being used in the imputation model
and 20 datasets were created.
Two-sided p< 0.05 was considered statistically signifi-
cant, and 95% confidence intervals (CI) are reported
where relevant. All results are given as the mean with
the SD in parentheses unless otherwise indicated.Ethics
All participants gave written informed consent to partici-
pation before enrolment in the study. The project was
approved by the Regional Committees for Medical Re-
search Ethics, and the Data Inspectorate, Oslo, Norway.
Table 1 Subject characteristics and dietary intake in subjects with and without IBS
Subject characteristics and food groups (% missing) IBS n=388 Non IBS n=4233 p
Female, % (0.0) 67.5 55.3 < 0.001
Age, years (0.0) 46.9 (13.4) 49.1 (13.9) 0.002
BMI, kg/m2 (0.2) 26.9 (4.5) 26.9 (4.2) 0.58
Education, years (1.0) 12.0 (3.5) 12.2 (3.5) 0.67
Number of diseases (0-9) (5.7) 1.0 (1.3) 0.5 (0.9) < 0.001
HSCL101 (1-4) (6.4) 1.6 (0.6) 1.3 (0.4) < 0.001
Musculoskeletal complaints (0-12) (28.9) 3.6 (2.9) 1.9 (2.1) < 0.001
Physical activity, hours/day (9.3) 2.8 (1.7) 3.0 (1.7) 0.020
Smoking, % (0.6) 32.7 27.9 0.045
Cholesterol, mmol/L (0.1) 5.6 (1.1) 5.7 (1.1) 0.036
HDL, mmol/L (0.1) 1.3 (0.4) 1.4 (0.4) 0.061
Triglycerides, mmol/L (0.2) 1.6 (1.0) 1.7 (1.1) 0.12
Glucose, mmol/L (0.5) 5.3 (1.3) 5.4 (1.4) 0.39
Creatinine clearance (0.2) 88.1 (25.8) 87.7 (25.5) 0.80
Systolic blood pressure, mm Hg (0.0) 127.1 (20.7) 130.3 (20.9) 0.002
Diastolic blood pressure, mm Hg (0.0) 73.2 (10.2) 74.4 (10.2) 0.028
Pulse, beats/minute (0.1) 72.5 (11.2) 71.9 (12.4) 0.23
Fruits and berries, g/day (1.3) 86.0 (74.8) 92.9 (76.0) 0.035
Vegetables, g/day (1.6) 150.5 (116.0) 147.4 (108.9) 0.87
Potatoes, g/day (0.7) 123.5 (83.4) 136.3 (88.0) 0.005
Dairy products, portions2/day (13.8) 2.2 (1.5) 2.6 (1.5) < 0.001
Water, 100 ml/day (1.1) 3.9 (1.9) 3.5 (1.9) 0.001
Carbonated beverages, 100 ml/day (0.7) 1.8 (2.1) 1.4 (1.6) <0.001
Coffee, 100 ml/day (0.6) 4.2 (3.8) 4.4 (3.3) 0.16
Tea, 100 ml/day (0.4) 1.7 (2.5) 1.3 (2.3) 0.003
Juice, 100 ml/day (5.2) 0.9 (1.2) 0.8 (1.0) 0.37
Alcohol, units3/day (4.1) 0.22 (0.50) 0.19 (0.29) 0.12
Omega 3 fatty acids4, g/day (4.3) 0.7 (0.7) 0.8 (0.7) 0.012
1 Hopkins Symptom Checklist 10 for mood disorders measurement.
2 Dairy product portions are defined as either 150 ml milk/yoghurt or 20 g (one slice) of cheese.
3 Units of alcohol are defined as 12.8 g (15 ml) of pure alcohol.
4 Omega 3 fatty acids are calculated from fatty fish and fish oil supplements.
From original data with Mann-Whitney U test/Chi-square test. Values are mean (SD) unless otherwise stated.
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Questionnaires about abdominal complaints and diet
were completed by 4621 subjects (Figure 1). Of the eli-
gible subjects, 388 (8.4%) men and women were diag-
nosed with IBS, and of these, 26.5% had C-IBS, 44.8%
A-IBS, and 28.6% D-IBS. The mean (SD) severity of
their symptoms was 3.2 (2.4).
Subjects with IBS had significantly lower intake of
dairy products and potatoes and significantly higher in-
take of water, tea and carbonated beverages than subjects
without IBS (Table 1). The population with IBS had a
significant higher score for number of diseases, mood
disorders and musculoskeletal complaints compared
with controls.A comparison of IBS subgroups showed a significant
higher intake of alcohol in subjects with D-IBS and A-
IBS compared to subjects with C-IBS (Table 2). There
were significantly more men with D-IBS. Moreover, the
severity of symptoms was significantly higher among
those with D-IBS compared to the other subgroups.
Multivariable analysis showed that a lower intake of
dairy products and a higher intake of water, tea and car-
bonated beverages were associated with IBS (Table 3).
Subjects with D-IBS had significantly lower intake of
dairy products and significantly higher intakes of alcohol
and carbonated beverages than subjects without IBS.
Furthermore, there was a significantly higher intake of
tea and water in subjects with A-IBS compared with
Table 2 Subject characteristics and dietary intake: comparison between subgroups of IBS
Subject characteristics and food groups C-IBS n =103 A-IBS n =174 D-IBS n =111 p
Age, years 48.3 (14.2) 46.0 (13.2) 47.0 (12.7) 0.51
Female, n, % 86 (83%) 123 (71%) 53 (48%) <0.001A
Severity of symptoms (1-12) 2.7 (2.3) 3.0 (2.3) 3.8 (2.5) <0.001B
Fruits and berries, 100 g/day 1.0 (0.7) 0.8 (0.7) 0.8 (0.8) 0.068
Vegetables, 100 g/day 1.7 (2.2) 1.5 (1.1) 1.4 (1.2) 0.10
Potatoes, 100 g/day 0.4 (0.9) 1.2 (0.8) 1.2 (0.8) 0.13
Dairy products, portions1/day 2.2 (1.5) 2.2 (1.6) 2.0 (1.4) 0.71
Omega 3 fatty acids2, g/day 0.7 (0.6) 0.7 (0.7) 0.7 (0.7) 0.87
Water, 100 ml/day 3.9 (1.9) 3.9 (2.0) 3.7 (1.9) 0.65
Juice, 100 ml/day 0.9 (1.2) 0.9 (1.1) 1.0 (1.2) 0.90
Carbonated beverages, 100 ml/day 1.4 (1.6) 1.9 (2.4) 2.0 (2.1) 0.13
Tea,100 ml/day 1.7 (2.2) 1.9 (2.6) 1.4 (2.6) 0.094
Coffee,100 ml/day 4.3 (3.5) 4.0 (4.2) 4.4 (3.3) 0.39
Alcohol, units3/day 0.1 (0.2) 0.2 (0.6) 0.3 (0.6) 0.006C
1 Dairy product portions are defined as either 150 ml milk/yoghurt or 20 g (one slice) of cheese.
2 Omega 3 fatty acids are calculated from fatty fish and fish oil supplements.
3 Units of alcohol are defined as 12.8 g (15 ml) of pure alcohol.
A A-IBS vs. D-IBS: p< 0.001; C-IBS vs. D-IBS: p< 0.001; C-IBS vs. A-IBS: p= 0.020 B A-IBS vs. D-IBS: p= 0.001; C-IBS vs. D-IBS: p< 0.001.
C C-IBS vs. A-IBS: p= 0.008; C-IBS vs. D-IBS: p= 0.003.
From original data with Kruskal Wallis Test/Mann-Whitney U test for continuous and Fisher exact test for dichotomous variables. Only age, gender, severity of
symptoms and food groups are shown. Values are mean (SD) unless otherwise stated.
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ences in diet between subjects with C-IBS compared to




n =388 vs 4233
C-IBS v
n =10
OR (95% CI) p OR (95%
Age, years 0.99 (0.97 to 1.00) 0.13 0.98 (0.96
Female 1.16 (0.85 to 1.60) 0.35 2.11 (1.18
Fruits and berries, 100 g/day 0.89 (0.75 to 1.05) 0.17
Vegetables, 100 g/day 1.16 (0.85 to 1.60) 0.13
Potatoes, 100 g/day 1.10 (0.97 to 1.24) 0.23
Dairy products, portions1/day 0.85 (0.78 to 0.93) 0.001 0.90 (0.76
Omega 3 fatty acids2, g/day 0.89 (0.73 to 1.09) 0.26
Water, 100 ml/day 1.08 (1.02 to 1.15) 0.002 1.08 (0.97
Juice, 100 ml/day 1.05 (0.94 to 1.16) 0.40
Carbonated beverages, 100 ml/day 1.07 (1.01 to 1.14) 0.023
Tea, 100 ml/day 1.05 (1.01 to 1.10) 0.019
Coffee, 100 ml/day 0.99 (0.96 to 1.02) 0.55
Alcohol, units3/day 1.216 (0.89 to 1.66) 0.22
1 Dairy product portions are defined as either 150 ml milk/yoghurt or 20 g (one slic
2 Omega 3 fatty acids are calculated from fatty fish and fish oil supplements.
3 Units of alcohol are defined as 12.8 g (15 ml) of pure alcohol.
A Adjusted for all variables from table 1. Age, gender, and all food items are shown.
B Adjusted for age, gender, HSCL10, musculoskeletal complaints, triglycerides, HDL,
gender, and food groups included in the analyses are shown.
C Adjusted for age, gender, HSCL10, musculoskeletal complaints, BMI, diastolic bloo
and berries, potatoes, milk products, carbonated beverages, tea, and alcohol Age, g
D Adjusted for age, gender, HSCL10, musculoskeletal complaints, BMI, systolic blood
gender, and food groups included in the analyses are shown.In subjects with IBS the severity of symptoms was sig-
nificantly associated with a high intake of vegetables in






n= 111 vs 4233
CI) p OR (95% CI) p OR (95% CI) p
to 1.01) 0.18 0.99 (0.97 to 1.01) 0.33 0.99 (0.97 to 1.01) 0.35
to 3.79) 0.012 1.61 (1.02 to 2.52) 0.040 0.74 (0.48 to 1.14) 0.17
0.81 (0.64 to 1.03) 0.081
0.85 (0.68 to 1.06) 0.15
to 1.06) 0.20 0.89 (0.78 to 1.01) 0.075 0.74 (0.63 to 0.86) < 0.001
to 1.20) 0.17 1.11 (1.02 to 1.21) 0.019 1.10 (0.99 to 1.22) 0.068
1.07 (0.98 to 1.16) 0.13 1.11 (1.00 to 1.22) 0.043
1.08 (1.03 to 1.14) 0.003
1.18 (0.79 to 1.77) 0.42 1.56 (1.01 to 2.42) 0.045
e) of cheese.
systolic blood pressure, creatinine clearance, dairy products, and water. Age,
d pressure, triglycerides, HDL, creatinine clearance, number of diseases,fruits
ender, and food groups included in the analyses are shownz.
pressure, HDL, water, milk products, carbonated beverages, and alcohol. Age,
Table 4 Severity of symptoms in subgroups of IBS associated to age, gender and food groups
Age, gender and food groups C-IBSAn =103 A-IBSBn= 174 D-IBSCn=111
OR (95% CI) p OR (95% CI) p OR (95% CI) p
Age, years 1.01 (0.97 to 1.04) 0.80 0.97 (0.93 to 1.00) 0.074 0.96 (0.91 to 1.02) 0.18
Female 0.93 (0.33 to 2.68) 0.90 0.16 (0.07 to 0.37) < 0.001 0.73 (0.29 to 1.84) 0.51
Fruits and berries, 100 g/day 0.75 (0.43 to 1.31) 0.31 1.93 (1.20 to 3.09) 0.006
Vegetables, 100 g/day 1.97 (1.31 to 2.98) 0.001 1.51 (1.08 to 2.13) 0.016
Potatoes, 100 g/day 0.53 (0.30 to 0.95) 0.034
Dairy products, portions1/day 0.90 (0.73 to 1.11) 0.33
Water, 100 ml/day 1.06 (0.91 to 1.24) 0.45
Juice, 100 ml/day 0.87 (0.66 to 1.15) 0.33
Carbonated beverages, 100 ml/day 1.16 (0.90 to 1.48) 0.25 0.92 (0.80 to 1.07) 0.28 1.37 (1.12 to 1.67) 0.002
Tea, 100 ml/day 1.07 (0.94 to 1.21) 0.30
Alcohol, units2/day 3.19 (1.62 to 6.28) 0.001
1 Dairy product portions are defined as either 150 ml milk/yoghurt or 20 g (one slice) of cheese.
2 Units of alcohol are defined as 12.8 g (15 ml) of pure alcohol.
A Adjusted for age, gender, HSCL10, musculoskeletal complaints, BMI, pulse, triglycerides, vegetables, potatoes, and carbonated beverages. Age, gender, and food
groups included in the analyses are shown.
B Adjusted for age, gender, HSCL10, musculoskeletal complaints, number of diseases, diastolic blood pressure, systolic blood pressure, triglycerides, creatinine
clearance, education, physical activity, fruits and berries, vegetables, milk products, water, juice, tea, and carbonated beverages,. Age, gender, and food groups
included in the analyses are shown.
C Adjusted for age, gender, HSCL10, musculoskeletal complaints, number of diseases, BMI, diastolic blood pressure, creatinine clearance, fruits and berries,
carbonated beverages, and alcohol. Age, gender, and food groups included in the analyses are shown.
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with D-IBS, the severity of symptoms was significantly
associated with higher intakes of carbonated beverages,
alcohol, and fruits and berries.
The blood values of omega-3 fatty acids of fish origin
(104.7 (37.8)) were significantly correlated with a diet
containing omega-3 fatty acids from fatty fish and fish
oil supplements (R2 = 0.421, p= 0.001).
Discussion
This study is the first one to show that the association
between IBS and dietary habits refers to the whole popu-
lation with IBS and not only those seeking medical ad-
vice. There were dietary differences between subjects
with and subjects without IBS, between IBS subgroups
and there were associations between diet and the severity
of symptoms. As this was a cross-sectional study the
possibilities for both cause and effect relationships are
discussed.
The lower intake of dairy products in IBS and particu-
larly D-IBS compared to subjects without IBS is consist-
ent with some studies that have shown avoidance of milk
products and lower intakes of calcium in subjects with
IBS compared to controls [10,11]. In contrast, other
studies have reported a higher intake of calcium or simi-
lar amounts of lactose in subjects with IBS/functional
gastrointestinal disorders compared to reference values
[5,12]. Some possible explanations of the variation of
study results in the intake of dairy products include cul-
tural variation and furthermore the subject’s experience
of symptoms connected to the intake of these productsand their subsequent avoidance. This fits with the lack
of association between the intake of dairy products and
the severity of symptoms. Overall recommendations are
to avoid lactose-containing products if these are sus-
pected to cause symptoms [13-15]. However, as lactose
malabsorption seems to be similarly distributed among
subjects with and without IBS [14,16], there may be
other components of milk besides lactose that cause
symptoms. Casein is a milk protein which coagulates in
the stomach and seems to be problematic to digest
[17,18]. One study showed associations between milk
protein intolerance and D-IBS and A-IBS [19]. Hista-
mine, a component in some cheeses, has also been
reported to cause IBS like symptoms, such as diarrhoea
and flatulence [20]. Another possible explanation
includes IgE- and IgG-mediated food hypersensitivity, of
which the role in IBS is inconclusive [15,21-25] The
lower intake of dairy products in subjects with IBS could
be a cause of IBS, but is probably an effect due to symp-
toms experienced following ingestion. The cause of these
symptoms is unknown.
A higher intake of vegetables was significantly asso-
ciated with an increased severity of symptoms in C-IBS
and A-IBS, and a higher intake of fruits and berries was
significantly associated with the severity of symptoms in
D-IBS. Other studies support these results [26,27]. Vege-
tables, such as brussel sprouts and beans, as well as fruits
such as prunes are reported to produce gas due to fer-
mentation, and subjects with IBS are reported to handle
gas poorly [28]. Some fruits can exert a laxative effect
due to their carbohydrate composition which may
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components of fruits and vegetables, has been suggested
to cause gut symptoms in susceptible individuals with
gastrointestinal disorders [30]. On the other hand as
psyllium and other soluble fibres are shown to reduce
symptoms in subjects with IBS [31,32], the higher intake
of vegetables seen in C-IBS and A-IBS may be an at-
tempt to soften the stool and reduce the symptoms
through the mechanisms of maintenance of a healthy
microflora and absorbing water [33]. Thus, the higher in-
take of fruits, berries and vegetables could be a combin-
ation of consequence or cause of symptoms.
The intake of water and tea was significantly higher in
A-IBS compared to subjects without IBS and the intake
of water and carbonated beverages was particularly high
in subjects with D-IBS. Plain water is recommended as a
beverage for subjects with IBS [34], while tea may be
constipating [35], and coffee, which was not associated
with IBS in our study, may be related to diarrhoea [31].
Tea contains salicylates, which may cause gut symptoms
[30]. There are recommendations to reduce or to replace
caffeine-containing products such as coffee and teas
[15,34]. The positive association of IBS with carbonated
beverages is consistent with the findings of one study
that showed a higher intake of cola in subjects with IBS
compared to controls [6]. One study reported more
gastrointestinal complaints induced by carbonated bev-
erages among subjects with IBS compared with controls
[26]. Thus, the higher intake of carbonated beverages
could be a cause of severe symptoms due to intakes of
carbonated beverages containing caffeine or other com-
ponents. Conversely, the intake of carbonated beverages
in addition to water could simply be an attempt to re-
place milk with other fluids or to increase the intake of
fluids to manage symptoms as recommended for both
constipation- and diarrhoea-related problems [36,37].
Subjects with D-IBS showed the highest intakes of al-
cohol compared with other subgroups and subjects with-
out IBS, and in this subgroup, there was a significant,
positive association between the intake of alcohol and
the severity of symptoms. In, contrast, Williams et al.
found no alcohol intake differences between IBS sub-
groups [12]. Supportive of our results, alcohol consump-
tion was associated with gastrointestinal symptoms in
other studies [4,38]. Two studies showed support for
stool softening properties of alcohol [35,39]. Hey et al.
suggested that alcohol may produce osmotic diarrhoea
through its high sugar content [40]. The higher intake of
alcohol may also just reflect an attempt to relieve severe
symptoms with alcohol.
There seems to be issues related to symptoms con-
cerning diary products, fruits and vegetables, carbonated
beverages and alcohol in subjects with IBS, but there
may be differences between subgroups regards what kindof item causes symptoms. The mentioned food items
may be discussed in dietary consultations, and the im-
portance of treating every patient with IBS individually is
herby emphasised.
The higher score for psychological distress measured
by HSCL10 and the higher score of musculoskeletal
complaints in subjects with IBS compared to subjects
without IBS are consistent with the results of other stud-
ies [41]. The higher percentage of women and the lower
age of the IBS population found in unadjusted analyses
were not associated with IBS in adjusted analyses, prob-
ably due to sex- and age related differences in diet. The
more severe symptoms among subjects with D-IBS is
consistent with the results of a previous study that found
a higher effect from severity of pain in persons with D-
IBS and A-IBS compared to those with C-IBS [42]. The
higher percentage of men among those with D-IBS is
consistent with the results of other studies [43].
Strengths and limitations
The strengths of this study were the design based on the
general population, which reduces the risk for a selection
bias, and that the sample size was high, which increases
the internal validity of the study and reduces the risk of
type II error. However, the response rate was low, which
might again induce a selection bias and reduce the exter-
nal validity. Still, a Norwegian study on non-responders
that shares many similarities with our study, such as time
period, design, and response rate, found no evidence of
major systematic errors [44]. As our study was con-
ducted in the general population, subjects with all grades
of severity and subjects who either visited or did not visit
doctors were included. Thus, the population with IBS is
heterogenic and the results may not be compared with
results from studies of merely referred subjects. One
other cross-sectional study from the general population
was conducted in the Western of Norway a few years
prior to our study [45]. The response rate was high
(77%). To the extent it was possible to compare the stud-
ies; there were no dietary principle differences between
this study and our study. The considered p-value< 0.05
might have increased the risk of a type I error, as we had
several outcome variables such as IBS yes/no, the sever-
ity of symptoms and the subtypes of IBS. The significant
and strong correlation between the blood omega-3 fatty
acids of fish origin and the self-reported diet of omega-3
fatty acids from fish and food supplements strengthens
the validity of the diet data.
The FFQ was unfortunately not validated, however the
food questions have been used and published by Lupton
[46] and the alcohol questions have been used in some
publications [47,48]. As a FFQ is somewhat restricted, it
is in general not able to catch the complete diet. The
FFQ in our study was additionally limited as it did not
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cereals and meat. Different types of fruits or vegetables
were not specified and as different fruits and vegetables
may exert different effects, the interpretation of the
results was difficult. As this was a limited FFQ we were
not able to collect data on energy intake or intake of
macronutrients. There were also no questions about food
frequency. Overestimation of food intake is a common
bias in FFQs such as ours. It is unlikely, however, that
the population with IBS should overestimate more or
less than the population without IBS.
Conclusions
Our population-based study shows differences in diet in
subjects with and without IBS. Some of the differences
are more pronounced in subgroups and the diet is asso-
ciated with the severity of symptoms. The results may
have importance for dietary advice. Future research
should include all food groups, try to find plausible
mechanisms underlying the dietary differences, and dif-
ferentiate between different subgroups of IBS.
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